Skip to main content
. 2012 Dec 3;12:335. doi: 10.1186/1471-2334-12-335

Table 2.

Comparison of selected risk factors for healthcare-associated infection or colonization with multidrug-resistant Acinetobacter baumannii in the intensive care unit from 1st September to 31st October 2009

Risk factors No. (%)
Odds ratio (95% CI) P value
Cases
Controls
(n = 7) (n = 19)
Age, y (mean (SD))
67.1 (22.9)
67.2 (16.9)
-
0.99
Male
5 (71.4)
12 (63.2)
1.46 (0.22–9.62)
1
Hospital stay, days [median (IQR)]
7 (4–61)
9 (3–47)
-
1
ICU stay, days [median (IQR)]
6 (4–8)
3 (2–6)
-
0.001
Blood transfusion
5 (71.4)
13 (68.4)
1.15 (0.17–7.74)
1
Mechanical ventilation
6 (85.7)
16 (84.2)
1.13 (0.10–13.04)
1
Bedside diagnostic ultrasonography
6 (85.7)
5 (41.7)
16.8 (1.60–176.23)
0.02
Bedside chest X-ray
7 (100.0)
4 (36.4)
-
<.001
Bronchofiberscopy
6 (85.7)
4 (21.1)
22.50 (2.07–244.84)
0.005
Electrocardiography
1 (14.3)
3 (15.8)
0.89 (0.08–10.30)
1
Venipuncture
7 (100.0)
12 (63.2)
-
0.13
Gastric lavage
7 (100.0)
12 (63.2)
-
0.13
Urinary catheterization
6 (85.7)
19 (100.0)
-
0.27
Hemodialysis
3 (42.9)
2 (10.5)
6.38 (0.78–51.78)
0.10
Presence of central line
2 (28.6)
2 (10.5)
3.40 (0.38–30.66)
0.29
Surgical operation
3 (42.9)
4 (36.4)
2.81 (0.44–18.06)
0.34
Septic shock
4 (57.1)
1 (5.3)
24.00 (1.95–295.06)
0.01
Multiple organ failure
3 (42.9)
1 (5.3)
13.50 (1.10–165.89)
0.05
Pulmonary diseases
6 (85.7)
8 (42.1)
8.25 (0.82–82.67)
0.08
Renal diseases
5 (71.4)
3 (15.8)
13.33 (1.71–103.75)
0.01
Fluoroquinolone administration
2 (28.6)
3 (15.8)
2.13 (0.27–16.60)
0.59
Carbapenem administration 5 (71.4) 1 (5.3) 45.00 (3.35–603.99) 0.002

CI confidence interval; ICU intensive care unit; IQR interquartile range; OR odds ratio; SD standard deviation; -, not measured; IQR interquartile range; ICU intensive care unit.